Many pharmaceutically important compounds derive from carbohydrate-containing natural products, and sugar moieties of these molecules have been proven to play an important role in drug targeting, biological activity, and pharmacology. [1±7] Thus, altering the glycosylation of natural products would significantly contribute to the diversity of novel therapeutics. Among a number of routes for altering glycosylation, naturalproduct glycorandomization is one of the most efficient approaches for complex secondary metabolites.[8±14] In vitro glycorandomization (IVG) technology establishes a promiscuous chemoenzymatic system to quickly build diverse glycorandomized libraries based on natural-product structures (Figure 1 a). This process utilizes chemical synthesis to provide a repertoire of unique sugar precursors, and three promiscuous enzymes to activate (anomeric sugar kinases and nucleotidylyltransferases) and attach (glycosyltransferases) these carbohydrate libraries to various complex natural-product aglycons. Anomeric sugar kinases, as key components of glycorandomization, directly determine the availability of sugar phosphates for chemoenzymatic routes toward complex glycoconjugates. Thus, generation of a flexible sugar kinase capable of accepting a wide array of monosaccharide substrates would directly enhance the efficiency of IVG. Of particular interest are d-glucoconfigured scaffolds given their prevalence in glycosylated natural products (Figure 1 b), [1,3,4,6] glycoproteins, [15±18] as well as many bacterial and eukaryotic cell-surface glycosylation patterns.[18±20]To date, an enzyme capable of d-glucose (Figure 2, 13) anomeric phosphorylation (a glucokinase, or GlcK) remains elusive. Toward this goal, directed evolution of E. coli galactokinase (GalK) led to the Y371H variant with remarkably widened substrate flexibility at C-2, C-3, and C-5 of the sugar. Yet, all sugars tested containing alternative C-4 substitutions (e.g. 4-deoxy-d-galactose, 12 or 13, Figure 2) were not accepted as substrates for the evolved catalyst.[21] As an alternative approach, the recently elucidated structure of Lactococcus lactis GalK provides a template for rational sugar kinase engineering.[22] The L. lactis GalK structure reveals that the strongly conserved active-site residues Asp45 and Tyr233 hydrogen bond with the critical galactose C-4 axial hydroxyl.[22] While a recent saturation mutagenesis of the equivalent residues within the E. coli GalK revealed the role of the active-site tyrosine to be hydrophobic stacking and expanded the substrate range to include 12, [23] a GlcK has still not been found. To continue our quest for an anomeric GlcK and further explore the relevance of the L. lactis structural model to other GalKs, we report the generation and characterization of the Y385H L. lactis GalK mutant-the promiscuous E. coli equivalent of which was discovered through directed evolution.[21] Remarkably, we reveal that this L. lactis variant displays a substantial degree of kinase activity toward several C-4-substitut...